Literature DB >> 12575983

The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells.

Luciano Cominacini1, Anna Fratta Pasini, Ulisse Garbin, Antonio Pastorino, Anna Rigoni, Cristina Nava, Anna Davoli, Vincenzo Lo Cascio, Tatsuya Sawamura.   

Abstract

OBJECTIVES: To address the potential role of the endothelial lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in the thrombotic system, in this study we first examined whether platelet interaction with LOX-1 generated reactive oxygen species (ROS) and superoxide (O2.-) and then investigated the relationship between the intracellular production of O2.- and the availability of nitric oxide (NO).
BACKGROUND: Oxidative inactivation of NO is regarded as an important cause of its decreased biologic activity which may favor platelet-dependent arterial thrombosis.
METHODS: Bovine aortic endothelial cells (BAECs) and Chinese hamster ovary-K1 cells stably expressing bovine LOX-1 (BLOX-1-CHO) were incubated at different times with human platelets. The ROS, O2.-, and NO were measured in cells by flow cytometry.
RESULTS: The incubation of BAECs and BLOX-1-CHO cells with human platelets induced a sharp and dose-dependent increase in intracellular concentration of ROS and O2.- (p from <0.01 to <0.001). The increase in intracellular concentration of O2.- was followed by a dose-dependent reduction in basal and bradykinin-induced intracellular NO concentration (p from <0.01 to <0.001). The increase in O2.- and the reduction of NO were inhibited by the presence of vitamin C and anti-LOX-1 monoclonal antibody (p < 0.001).
CONCLUSIONS: The results of this study show that one of the pathophysiologic consequences of platelet binding to LOX-1 may be the inactivation of NO through an increased cellular production of O2.-.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12575983     DOI: 10.1016/s0735-1097(02)02811-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  12 in total

Review 1.  Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis.

Authors:  Sanjiv Singh; Avtar Singh Gautam
Journal:  Curr Atheroscler Rep       Date:  2019-07-27       Impact factor: 5.113

Review 2.  Oxidative Stress in Atherosclerosis.

Authors:  Ajoe John Kattoor; Naga Venkata K Pothineni; Deepak Palagiri; Jawahar L Mehta
Journal:  Curr Atheroscler Rep       Date:  2017-09-18       Impact factor: 5.113

3.  Abrogation of lectin-like oxidized LDL receptor-1 attenuates acute myocardial ischemia-induced renal dysfunction by modulating systemic and local inflammation.

Authors:  Jingjun Lu; Xianwei Wang; Wenze Wang; Harish Muniyappa; Abhishek Deshmukh; Changping Hu; Kumuda Das; Jawahar L Mehta
Journal:  Kidney Int       Date:  2012-08       Impact factor: 10.612

Review 4.  LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.

Authors:  Suowen Xu; Sayoko Ogura; Jiawei Chen; Peter J Little; Joel Moss; Peiqing Liu
Journal:  Cell Mol Life Sci       Date:  2012-11-03       Impact factor: 9.261

Review 5.  Atherosclerosis: integration of its pathogenesis as a self-perpetuating propagating inflammation: a review.

Authors:  Robin N Poston
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-05-15

6.  LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells.

Authors:  Jane E Murphy; Daryl Tacon; Philip R Tedbury; Jonathan M Hadden; Stuart Knowling; Tatsuya Sawamura; Michelle Peckham; Simon E V Phillips; John H Walker; Sreenivasan Ponnambalam
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

Review 7.  The discovery of LOX-1, its ligands and clinical significance.

Authors:  Ryo Yoshimoto; Yoshiko Fujita; Akemi Kakino; Shin Iwamoto; Tomohide Takaya; Tatsuya Sawamura
Journal:  Cardiovasc Drugs Ther       Date:  2011-10       Impact factor: 3.727

Review 8.  Scavenger receptor structure and function in health and disease.

Authors:  Izma Abdul Zani; Sam L Stephen; Nadeem A Mughal; David Russell; Shervanthi Homer-Vanniasinkam; Stephen B Wheatcroft; Sreenivasan Ponnambalam
Journal:  Cells       Date:  2015-05-22       Impact factor: 6.600

9.  Risk factors in coronary atherosclerosis athero-inflammation: the meeting point.

Authors:  Raul Altman
Journal:  Thromb J       Date:  2003-07-17

Review 10.  LOX-1, OxLDL, and atherosclerosis.

Authors:  Angela Pirillo; Giuseppe Danilo Norata; Alberico Luigi Catapano
Journal:  Mediators Inflamm       Date:  2013-07-10       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.